Latest News in the pharma Industry
All
Evotec completes acquisition of Aptuit
16 Aug 2017
Employees and capabilities will be integrated into Evotec's global drug discovery group to maximise commercial synergies.
Read more
Vectura signs global development agreement with Dynavax
16 Aug 2017
Agreement convers the clinical application of Vectura's proprietary smart nebuliser technology to deliver Dynavax's investigational immunotherapeutic agent to lung cancer patients.
Read more
Metacrine collaborates on development of FGF1 variants for glucose lowering and improving insulin sensitivity
16 Aug 2017
Novo Nordisk will have an option to license the FGF1 program upon achievement of certain research milestones.
Read more.jpg)
Abcam and TTP Labtech collaborate to develop sol-R reagent kits
16 Aug 2017
Assay-ready kits will incorporate fully-validated, industry-leading recombinant antibody technology for high throughput research.
Read more
The Great Hall of China: double digit growth at CPhI China
15 Aug 2017
The Asian pharma event surpasses 55,000 visits with more than 10,000 overseas visits.
Read more
Bespoke filtration equipment enables pharma manufacturer to fulfil contract
15 Aug 2017
Major pharma manufacturer delivers critical drugs to a leading children's hospital.
Read more
Cambridge Epigenetix and NuGEN Technologies combine leading technologies in epigenetics research
15 Aug 2017
Co-exclusive global licence covers manufacture and integration of CEGX TrueMethyl technology for oxidative bisulfite sequencing with Targeted Methylation and NuGEN Ovation Methyl-Seq systems.
Read more
Shire submits lifitegrast MAA for treatment of dry eye disease in Europe
15 Aug 2017
Lifitegrast, if approved, would be the first and only new class treatment to address the signs and symptoms of dry eye disease in adults in Europe.
Read more
Regeneron to discontinue development of suptavumab for respiratory syncytial virus
14 Aug 2017
Phase III study fails to meet its primary endpoint.
Read more
Ionis to go it alone with Inotersen and IONIS-FB-L Rx after GSK decline
14 Aug 2017
Inotersen on track for marketing authorization filings this year.
Read more
Fortress Biotech forms new subsidiary, Aevitas Therapeutics
14 Aug 2017
Subsidiary to develop novel AAV gene therapy treatments for complement-mediated.
Read more
Kalytera submits Phase II study protocol to IRBs for cannabidiol in the prevention of GvHD
14 Aug 2017
The Phase II study is designed to generate the pharmacokinetic and safety data, at multiple dose levels, that will be required by the FDA.
Read more